Skip to main content
Premium Trial:

Request an Annual Quote

Platypus Technologies Gets $396K Grant for HTS Platform

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Platypus Technologies has received a $396,000 grant from the National Cancer Institute to develop a high-throughput screening system for cancer therapeutics.

The two-year grant will fund the further development of Platypus' Oris assay format into a 384-well cell migration assay suitable for high-throughput screening of chemical libraries for cancer therapeutics.

"This intended product has the potential to streamline the drug discovery process by facilitating rapid screening of molecular libraries for development of therapeutics that block cancer cell metastasis and lead to novel cancer drugs," Platypus Technologies President and CEO Richard Schifreen said in a statement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.